Document:

GLOBALOPTIONS GROUP, INC.

415 Madison Avenue, 17th Floor

New York, NY 10017

 

March 26, 2012

 

Jeffrey O. Nyweide, CFO and E.V.P. Corp. Dev.

GlobalOptions Group, Inc.

415 Madison Avenue

17th Floor

New York, NY 10017

 

		Re:	Your Employment Agreement dated July 30, 2007, amended August 13, 2009, amended May 12, 2010, and amended December 12, 2010
(collectively the “Agreement”; capitalized terms used herein without definitions have the meanings specified in the
Agreement)

 

Dear Jeffrey:

 

With the Board of Directors providing instructions
to management to begin the process of utilizing the Company’s public reporting aspects to examine possible mergers or acquisitions
to enhance the value of its stock, the Company due to change of circumstances, desires that you now serve on a full time basis
versus your present part time basis as Chief Financial Officer, Executive Vice President of Corporate Development, and Secretary,
and to serve in such capacities through December 31, 2012 rather than July 31, 2012 as contemplated by the December 14, 2010 amendment.
This letter (the “Amendment”) is to modify and clarify the Agreement, effective as of March 1, 2012.

 

1.          The
parties hereby acknowledge that the current term of your employment was extended to July 31, 2012 by the operative provisions contained
in Section 1 of the Agreement, subject to earlier termination or amendment as contemplated therein. Accordingly, Section 1 is amended
and restated as follows:

 

 

    	1

    	 

    

 

 

“The Company agrees to continue your employment
as Chief Financial Officer, Treasurer, Secretary, and Executive Vice President Corporate Development for the Company until December
31, 2012. As Chief Financial Officer, Treasurer, Secretary, and Executive Vice President Corporate Development of the Company,
you shall report to the Chairman and shall have such responsibilities and perform such duties appropriate to such positions as
the Chairman determines, including but not limited to: (i) assisting the Company in the development of its business plan, and financial
forecasts; (ii) assisting the Company in developing its business strategy; (iii) assisting the Company in its investor relations,
including but not limited to, establishing tools and procedures for evaluating the Company’s existing financing and tracking
the Company’s performance; (iv) assisting the Company in examining possible mergers and/or acquisitions; and (v) assisting
the Company in raising additional financing. You shall devote sufficient working time and efforts to the business of the Company,
except that the Company agrees to and supports your continued participation in the activities set forth on Schedule A attached
hereto (and said Schedule A, may be amended from time to time hereafter), provided those activities do not interfere with your
responsibilities and your ability to perform your duties as set forth herein. The Company understands that your principal office
shall continue to be located at PO Box 1426, Manchester Center, VT 05255 and you will not be required to spend more than ten (10)
days per month in the City of New York to fulfill your obligations to the Company. Provided however, you shall telecommute from
your principal office and/or other facilities of the Company to perform your expected duties to the Company. The term shall not
automatically extend for an additional one year period at the end of the term, however, that the Company and you may amend this
Agreement prior to the end of the term as they shall mutually agree in writing. The end of such term shall be the “Expiration
Date”.”

 

2.          Section
2 is hereby amended and restated as follows:

 

“Salary: (a) Effective
as of March 1, 2012, and for the remainder of the term (December 31, 2012), the Company shall pay you a base salary per month in
the amount of $31,250, payable on the first of each month, in arrears and all other payments and Benefits provided for in the Agreement,
including Section 4 hereof at a level equivalent to the level in effect on the date of the Letter Amendment dated May 12, 2010
(as it may be increased (but not decreased) in the discretion of the Compensation Committee, “Base Salary”). If the
Company elects to extend the term beyond December 31, 2012, the Base Salary for part time shall be $20,000 per month and all Benefits
shall continue.

 

(b) In addition to the Base Salary and Benefits,
as an inducement for the Employee to remain in the employ of the Company, the Employee shall be eligible for a vested equity in
the amount of 75,000 shares of stock options at a strike price of $3.05 per share (such price being no less than the “fair
market value” for purposes of Section 409A of the Code (as defined below)) vesting six months from the date hereof with a
five year term. Provided, however, if termination occurs prior to the vesting period without cause, the options shall vest on the
termination date. The Company will permit cashless exercise of the stock options for the Employee. Notwithstanding anything contained
in this Agreement, upon a termination of employment without Cause or for Good Reason (which Good Reason shall not include the Change
of Control that may occur prior to March 31, 2012,) or as a result of death or Disability prior to the end of the term or any extension
thereto, the Employee shall receive the Base Salary and continued Benefits pursuant to Section 4 of this Agreement through the
end of the term. Provided, however, if the Company enters into an agreement to acquire or merge with or into an operating company
(a “Sale”), and upon the closing date of such acquisition or merger (the “Closing Date”), your employment
and the term of this Agreement shall terminate on the Closing Date and the Employee shall receive a severance payment equal to
twelve (12) months of his part-time base salary ($15,000 per month) plus all Benefits under Section 4 and office space (equivalent
to $1,500 per month for office space) with all cash payments for said twelve-month period to be paid in a lump sum within thirty
(30) days of the date of termination. Provided, further, the severance payment shall be reduced by an amount equal to $15,000 times
the number of completed months the Employee worked from March 1, 2012 to the date of termination due to an acquisition or merger.
For clarity, if the Employee for example is terminated due to the Company entering into and closing an acquisition on July 31,
2012, and the Employee is terminated on the same date, his severance payment will be reduced by $75,000 ($15,000 x five months).
Notwithstanding the foregoing, in the event that your employment is terminated without Cause or Good Reason and a Sale is consummated
within the later of six months of the date of termination or the end of the term, the Employee shall be entitled to the enhanced
severance as described above.3.          For the sake of clarity, the obligations
under Section 12 of the Agreement shall end on the last day of the term.

 

    	2

    	 

    

 

4.          In
the event that it is ultimately determined that the payment of the amounts held in the rabbi trust or hereunder were made in violation
of Section 409A of the Code, the Company shall pay or fully indemnify the Employee for all costs associated with such determination,
including without limitation, any additional tax, interest or legal fees.

 

5.          Section
25 is amended and restated as follows:

 

“Professional Fees.
The Company agrees to pay you in one lump sum personal accounting and legal fees relating to, and upon the execution of, the Amendment
up to a maximum of $10,000.00 on an after tax basis.”

 

Except as hereby amended, the Agreement and all of its terms
and conditions shall remain in full force and effect and are hereby confirmed and ratified. All references to the Agreement shall
be deemed references to the Agreement as amended and clarified hereby. This Amendment shall be governed and construed under the
laws of the State of New York.

 

Please sign below to acknowledge your agreement to and acceptance
of this Amendment to the Agreement.

 

	 	Sincerely,
	 	 
	 	/s/ Harvey Schiller
	 	Harvey Schiller
	 	Chairman & CEO

 

	Agreed to:	 
	 	 
	Jeffrey O. Nyweide	 
	Jeffrey O. Nyweide	 
	 	 
	Date:       March 26, 2012	 

 

    	3SUPPORT AGREEMENT

 

THIS SUPPORT AGREEMENT,
dated March 27, 2012, is by and among Genesis Capital Advisors LLC, a Delaware limited liability company (“Genesis Advisors”),
Genesis Opportunity Fund, L.P., a Delaware limited partnership (“Genesis Opportunity”), and Genesis Asset Opportunity
Fund, L.P., a Delaware limited partnership (“Genesis Asset Opportunity” and together with Genesis Advisor and Genesis
Opportunity, the “Stockholder”), and GlobalOptions Group, Inc., a Delaware corporation (the “Company”).

 

WITNESSETH:

 

WHEREAS, the Stockholder
owns of record and/or beneficially as of the date hereof, as set forth on Exhibit A hereto, 1,708,829 shares of the Company’s
common stock, par value $0.001 per share (the “Common Stock”), and as a result of which the Stockholder may be deemed
to beneficially own such shares, which together with any additional shares of Common Stock that the Stockholder or any “affiliate”
(as such term is defined in Rule 405 of the Securities Act of 1933, as amended) of the Stockholder may be deemed to beneficially
own on or after the date hereof, are referred to herein as “Owned Shares”;

 

WHEREAS, the Company
intends to hold an annual meeting of stockholders during 2012 (including any adjournments or postponements thereof, the “Annual
Meeting”); and

 

WHEREAS, the Stockholder
and the Company have determined that the best interests of all the stockholders of the Company would be served by the consummation
of the arrangements set forth herein.

 

NOW, THEREFORE, in
consideration of the promises, mutual representations, warranties, covenants and agreements set forth herein, and other good and
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be legally bound, the parties
hereto hereby agree as follows:

 

Section
1.        Representations and Warranties of the Company.

 

1.1               The
Company hereby represents, warrants and agrees that (a) it has full legal right, power and authority to execute, deliver and perform
this Agreement, and consummate the transactions contemplated hereby, (b) the execution and delivery of this Agreement, and the
consummation by the Company of the transactions contemplated hereby have been duly authorized by all necessary corporate actions,
and (c) this Agreement constitutes valid, legal and binding obligations of the Company, enforceable against it in accordance with
its terms, except that such enforcement may be subject to bankruptcy, insolvency, reorganization, moratorium (whether general or
specific) or other laws now or hereafter in effect. The performance of the terms of this Agreement shall not conflict with, constitute
a violation of, or require any notice or consent under, the Company’s Certificate of Incorporation, as amended (the “Certificate
of Incorporation”), the Company’s By-Laws, as amended (the “By-Laws”), or any agreement or instrument to
which the Company is a party or by which the Company is bound, and shall not require any consent, approval or notice under any
provision of any judgment, order, decree, statute, rule or regulation applicable to the Company.

 

    	 

    	 

    

 

Section
2.        Representations and Warranties of the Stockholder.

 

2.1                The
Stockholder hereby represents, warrants and agrees that (a) it has full legal right, power and authority to execute, deliver and
perform this Agreement, and consummate the transactions contemplated hereby, (b) the execution and delivery of this Agreement,
and the consummation by the Stockholder of the transactions contemplated hereby have been duly authorized by all necessary actions,
and (c) this Agreement constitutes valid, legal and binding obligations of the Stockholder, enforceable against the Stockholder
in accordance with its terms, except that such enforcement may be subject to bankruptcy, insolvency, reorganization, moratorium
(whether general or specific) or other laws now or hereafter in effect. The performance of the terms of this Agreement shall not
conflict with, constitute a violation of, or require any notice or consent under, the organizational documents of the Stockholder
or any agreement or instrument to which the Stockholder is a party or by which the Stockholder is bound, and shall not require
any consent, approval or notice under any provision of any judgment, order, decree, statute, rule or regulation applicable to the
Stockholder. All Owned Shares (a) are, and shall be as of the date of the Annual Meeting and any other applicable Voting Event
(as defined below), held free and clear of all liens and encumbrances (other than ordinary course general liens in favor of a broker-dealer),
and (b) shall not be subject to any proxies (other than pursuant to this Agreement) as of the date of the Annual Meeting and any
other applicable Voting Event. Except for this Agreement, as of the date hereof, the Owned Shares are not, with respect to the
voting or transfer thereof, subject to any other agreement or third party rights, including any voting agreement, stockholders
agreement, irrevocable proxy or voting trust.

 

Section
3.        Actions by the Stockholder and the Company.

 

3.1                Voting.
From and after the date hereof until the End Date (as defined below), at the Annual Meeting, however called, and in response to
any request for any written consent of the stockholders of the Company, the Stockholder shall be present (in person or by proxy)
and vote (or cause to be voted) all of the Owned Shares in favor of the election of all director nominees recommended by the Company’s
Board of Directors (the “Board”) at the Annual Meeting or pursuant to such written consent. Any Owned Shares with respect
to which the Stockholder does not have voting power as of the date hereof or as of the record date of the Annual Meeting or date
of the written consent (or the record date with respect thereto) shall not be considered “Owned Shares” for the purposes
of this Section 3.1.

 

3.2                Irrevocable
Proxy. Solely with respect to the matters described in Section 3.1 hereof, if the Stockholder has not taken a Qualifying Action
(as defined below) on or prior to the third (3rd) business day prior to the Annual Meeting or any other meeting, date
or event upon which stockholders of the Company will be asked to vote with respect to the matters described in Section 3.1 (any
such meeting, date or event, the “Voting Event”), the Stockholder hereby irrevocably appoints each of Harvey W. Schiller,
Ph.D. and Jeffrey O. Nyweide as its proxy with full power of substitution (which proxy is irrevocable and which appointment is
coupled with an interest, including for purposes of all applicable provisions of the Delaware General Corporation Law) to vote
in his discretion all Owned Shares on the matters described in Section 3.1 effective from and after such third (3rd)
business day prior to the Annual Meeting or any other Voting Event and until the date that is the earlier of (i) six (6) months
after the date of the applicable Annual Meeting or other Voting Event or (ii) the End Date. The Stockholder agrees to execute any
further agreement or form reasonably necessary or appropriate to confirm and effectuate the grant of the proxy contained herein.
“Qualifying Action” means either (a) the delivery by the Stockholder to the Company of a copy of the Stockholder’s
duly executed and valid proxy (and any amendment of such proxy) with respect to the Annual Meeting or other Voting Event, provided
the votes reflected in such proxy or amendment thereof are consistent with the Stockholder’s voting obligations under this
Agreement with respect to the matter(s) in question or (b) the delivery by the Stockholder to the Company of a written certificate
signed by the Stockholder certifying that it shall attend the Annual Meeting or other Voting Event in person (if a meeting of stockholders)
and vote the Owned Shares in accordance with Section 3.1 hereof; provided that in the event that a Qualifying Action is subsequently
rescinded, revoked or modified in any manner inconsistent with the requirements of Section 3.1, or if the Stockholder does not
attend and vote as required hereunder at the Annual Meeting or other Voting Event, the Stockholder shall be deemed to have affirmed
as of the time of the Annual Meeting or other Voting Event the proxy with respect to the Owned Shares granted under this Section
3.2 (notwithstanding any other action taken since the date hereof) and each of Harvey W. Schiller, Ph.D. and Jeffrey O. Nyweide
shall be entitled to the proxy and vote the Owned Shares in his discretion at or in connection with the applicable Annual Meeting
or other Voting Event. Any Owned Shares with respect to which the Stockholder does not have voting power as of the date hereof
or as of the record date of the Annual Meeting, other Voting Event or date of any written consent (or the record date with respect
thereto), shall not be considered “Owned Shares” for the purposes of this Section 3.2.

 

    	-2-

    	 

    

 

3.3                 Standstill.
The Stockholder agrees that during the period commencing on the date hereof and ending on the earlier of (a) the 18 month anniversary
of the date hereof or (b) the consummation of a Change of Control (as defined below) (the “End Date”), the Stockholder
will not, and it will cause each of its affiliates and representatives (other than any such affiliate or representative who is
a director of the Company and acting in his or her capacity as a director of the Company) not to, directly or indirectly, alone
or in concert with others, take any of the actions set forth below, unless explicitly permitted pursuant to the terms of this Agreement
or mutually agreed upon in writing by each of the Stockholder and the Company:

 

(a)        effect,
seek, offer, propose (whether publicly or otherwise) or cause or participate in any discussions or negotiations regarding, or assist,
encourage or seek to persuade, any other person or entity to effect, seek, offer or propose (whether publicly or otherwise) or
participate in any discussions or negotiations regarding:

 

(i)        any
tender offer or exchange offer involving Common Stock, not including any tender offer made by the Company;

 

(ii)        any
recapitalization, restructuring, dividend, distribution, self tender, stock repurchase, liquidation, dissolution or other extraordinary
transaction with or involving the Company or any of its subsidiaries or any portion of the business or the assets of the Company
or any of its subsidiaries except for a merger, consolidation, share exchange, business combination or sale of assets with respect
to the Company or any of its subsidiaries (with respect to which the Stockholder shall be permitted to engage in any of the activities
set forth in Section 3.3(a) hereof so long as (A) the Stockholder refrains from making any public disclosures regarding such a
transaction in a broad, non-exclusionary manner and (B) the Board has not asked the Stockholder, in writing and pursuant to a duly
adopted resolution, to cease such activities with respect to a particular transaction after its presentation to the Board); or

 

    	-3-

    	 

    

 

(iii)        any
“solicitation” (as such term is used in the proxy rules of the Securities and Exchange Commission (the “SEC”))
of proxies or written consents with respect to the Company or any action resulting in such person or entity becoming a “participant”
(as such term is used in the proxy rules of the SEC) in any solicitation of proxies or written consents with respect to the Company;

 

(b)        except
as set forth herein, submit any nomination of an individual for election to the Board or any other proposal for consideration at
any annual or special meeting of the stockholders of the Company, including proposals pursuant to Rule 14a-8 promulgated under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”);

 

(c)        seek
to advise, encourage, support or influence any person with respect to the voting or disposition of any securities of the Company
in connection with the election of directors or any other proposal contrary to the recommendation of the Board;

 

(d)        form,
join or in any way participate in any “group” (other than a “group” comprised of solely affiliates) pursuant
to Rule 13d-5 promulgated under the Exchange Act with respect to any securities of the Company;

 

(e)        seek
to call any meeting of the holders of the Common Stock, amend any provision of the Certificate of Incorporation or the By-Laws,
reconstitute the composition of the Board or control the management or policies of the Company;

 

(f)        take
any action that could reasonably be expected to force the Company to make any public disclosure with respect to any of the types
of matters described in clauses (a) through (e), or announce any intention to take any action of the type described in clauses
(a) through (e); or

 

(g)        enter
into any negotiations, arrangements or understandings with any person or entity other than the Company with respect to any of the
foregoing, or advise, assist, or seek to persuade others to take any action with respect to any of the foregoing.

 

3.4        Board
Resolution Regarding Rights Agreement. The Board has duly adopted resolutions providing that (i) the Stockholder, together
with its affiliates, will not be deemed to be an “Acquiring Person” for the purposes of that certain Rights Agreement,
dated as of September 7, 2010, by and between the Company and Continental Stock Transfer & Trust Company (the “Rights
Agreement”) unless and until the Stockholder becomes the “Beneficial Owner” (as defined under the Rights Agreement)
of in excess of 35% of the outstanding Common Stock, and (ii) approves, solely for the purposes of Section 203 of the Delaware
General Corporation Law, the acquisition of the Owned Shares by the Stockholder. Such resolutions, as certified by the Company’s
Secretary, are attached hereto as Exhibit B. During the term of this Agreement (and in no event prior to the End Date),
the Board may not, in any manner change the definition of “Acquiring Person” with respect to the Stockholder and its
affiliates absent the Stockholder’s prior written consent.

 

    	-4-

    	 

    

 

3.5                 Appointment
of Director.

 

(a)        On
or before April 2, 2012, the Board shall vote to expand the Board to six (6) members and appoint two (2) designees of the Stockholder
(the “Stockholder Designees”) to serve on the Board.  The Board shall nominate and recommend the election of the
Stockholder Desginees to the Board, and solicit proxies for the Stockholder Designees to the Board, at the Annual Meeting, any
other Voting Event or any action by written consent. At such time the Stockholder beneficially owns less than 22% of the Common
Stock of the Company, the Stockholder shall only have the authority to appoint one (1) Stockholder Designee to the Board and the
Board shall only be required to nominate and recommend the election of such one (1) Stockholder Desginee to the Board, and solicit
proxies for such one (1) Stockholder Designee to the Board, at the Annual Meeting, any other Voting Event or any action by written
consent. At such time the Stockholder beneficially owns less than 10% of the Common Stock of the Company, the Stockholder shall
have no authority to appoint any Stockholder Designee to the Board and the Board shall have no obligation to nominate and recommend
the election of any such Stockholder Desginee to the Board, and solicit proxies for any such Stockholder Designee to the Board,
at the Annual Meeting, any other Voting Event or any action by written consent.

 

(b)        So
long as either of the Stockholder Designees serve on the Board, the Company shall maintain, without any interruption, and fully
pay the premium for, a minimum of $10,000,000 of non-cancellable directors and officers’ insurance from an insurance carrier
with the same or better credit rating as the Company’s current directors and officers’ insurance carrier, with other
terms and conditions that are no less favorable than the coverage provided under the Company’s existing policies with respect
to any actual or alleged error, misstatement, misleading statement, act, omission, neglect, breach of duty or any matter claimed
against a director or officer of the Company or any of its subsidiaries by reason of him or her serving in such capacity.

 

    	-5-

    	 

    

 

Section
4.        Certain Covenants of the Stockholder and the Company.

 

4.1                 Restriction
on Transfer, Proxies and Non-Interference.  The Stockholder hereby agrees from and after the date hereof until the
applicable date set forth below not to (a) sell, transfer, pledge, encumber, assign or otherwise dispose of, or enter into any
contract, option or other arrangement or understanding other than this Agreement with respect to the sale, transfer, pledge, encumbrance,
assignment or other disposition of, or limitation on the voting rights of, those 1,385,529 shares of Common Stock that the Stockholder
acquired from Brookdale Global Opportunity Fund, a Cayman company, and Brookdale International Partners, L.P., a New York limited
partnership and (collectively, the “Weiss Acquired Shares”), (b) grant any proxies or powers of attorney with respect
to any Weiss Acquired Shares (other than as set forth in this Agreement), deposit any Weiss Acquired Shares into a voting trust
or enter into a voting agreement with respect to any Weiss Acquired Shares (or attempt or purport to revoke or supersede the proxy
granted to the Company hereunder), (c) take any action that reasonably could cause any representation or warranty of the Stockholder
contained herein to become materially untrue or incorrect or have the effect of preventing or disabling the Stockholder from performing
its covenants or other obligations under this Agreement or (d) commit or agree to take any of the foregoing actions. Any transfer
of any Weiss Acquired Shares in violation of this provision shall be null and void. If any involuntary transfer of any Weiss Acquired
Shares shall occur (including a sale by the Stockholder’s trustee in any bankruptcy, or a sale to a purchaser at any creditor’s
or court sale), the transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of
the initial transferee) shall take and hold such Weiss Acquired Shares subject to all of the restrictions, liabilities and rights
under this Agreement. The restrictions under this Section 4.1 shall continue in full force and effect until a Change of Control;
provided, however, that (i) the Stockholder may, prior to the date of a Change of Control, sell, transfer, pledge, encumber, assign
or otherwise dispose of the Weiss Acquired Shares in blocks of 5% or more of the then issued and outstanding shares of Common Stock
of the Company to any party who agrees in writing with the Company to abide by and be bound by all of the of the terms, conditions,
restrictions, rights and liabilities contained in this Agreement, and (ii) following the six month anniversary of this Agreement,
the Stockholder may also sell, transfer, pledge, encumber, assign or otherwise dispose of the Weiss Acquired Shares in blocks of
less than 5% of the then issued and outstanding shares of Common Stock of the Company, (A) in privately negotiated transactions
where any transferee or pledgee of such shares will not following such disposition beneficially own more than 5% of the then issued
and outstanding shares of Common Stock of the Company, and (B) in transactions on a nationally recognized exchange or a nationally
recognized over-the-counter market (including, without limitation, the OTC Bulleting Board electronic quotation medium regulated
by the Financial Industry Regulatory Authority, Inc., the OTCQX maintained by OTC Markets Group Inc., the OTCQB maintained by OTC
Markets Group Inc. and any of their respective successors), so long as the Stockholder does not know that any acquirer of such
shares following such transaction will be the beneficial owner of more than 5% of the then issued and outstanding shares of Common
Stock of the Company; provided further however that in no event shall the restrictions in this Section 4.1 continue beyond December
31, 2012. In order to be able to enforce this Section 4.1, the Stockholder hereby consents to the certification of the Weiss Acquired
Shares and the placing of a legend/and or stop-transfer order on such shares with the transfer agent of the Common Stock. For purposes
of this Section 4.1, in determining the number of outstanding shares of Common Stock, the Stockholder may rely on the number of
outstanding shares of Common Stock as reflected in (x) the Company’s most recent Form 10-Q or Form 10-K, as the case may
be, (y) a more recent public announcement by the Company or (z) any other notice by the Company or the Company’s transfer
agent setting forth the number of shares of Common Stock outstanding.

 

4.2                 Change
of Control. For purposes of this Agreement, a “Change of Control” shall mean the occurrence of any one or more
of the following events: 

  

(a)        A
change in the composition of the Board such that the individuals who, as of the date hereof, other than any designee designated
by Weiss Asset Management LP pursuant to that certain Support Agreement dated October 27, 2010, by and between the Company and
Weiss Asset Management LP, and following the appointment of the Stockholder Designees, constitute the Board (such Board shall be
hereinafter referred to as the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board;
provided, however, that, for purposes of this Section 4.2(a), any individual who becomes a member of the Board subsequent to the
date hereof, whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least
a majority of those individuals who are members of the Board and who were also members of the Incumbent Board (or deemed to be
such pursuant to this proviso) shall be considered as though such individual were a member of the Incumbent Board; provided, further,
that any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest
(as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation
of proxies or consents by or on behalf of a person or entity other than the Board shall not be so considered as a member of the
Incumbent Board; or

  

    	-6-

    	 

    

  

(b)        The
consummation of a reorganization, merger, share exchange or consolidation or sale or other disposition of all or substantially
all of the assets of the Company (a “Corporate Transaction”); excluding, however, such a Corporate Transaction pursuant
to which (A) all or substantially all of the individuals and entities who are the beneficial owners, respectively, of the Company’s
outstanding Company Common Stock immediately prior to such Corporate Transaction will beneficially own, directly or indirectly,
more than 50% of the outstanding shares of common stock, and the combined voting power of the then-outstanding voting securities
entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Corporate
Transaction (including, without limitation, a corporation that as a result of such transaction owns the Company or all or substantially
all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as
their ownership, immediately prior to such Corporate Transaction, of the Company’s outstanding Common Stock or (B) individuals
who were members of the Incumbent Board will constitute at least a majority of the members of the board of directors of the corporation
resulting from such Corporate Transaction; or

 

(c)        The
approval by stockholders of a complete liquidation or dissolution of the Company.

 

4.3                 Registration
Rights Agreement. Concurrently with the execution of this Agreement, the Company and the Stockholder shall enter into a Registration
Rights Agreement, in the form attached hereto as Exhibit C, pursuant to which the Company shall agree to register the resale
of the Owned Shares pursuant to the terms set forth therein.

 

Section
5.        Miscellaneous.

 

5.1                 Public
Announcements. The Company agrees to issue a press release announcing the Company’s entry into this Agreement and/or
file a Form 8-K with the Securities and Exchange Commission (the “Public Statement”), which Public Statement must be
reasonably satisfactory to the Stockholder. None of the parties hereto shall (i) make any public statements regarding the Annual
Meeting or the terms and provisions of this Agreement (including in any filing with the SEC or any other regulatory or governmental
agency, including any stock exchange) that are inconsistent with, or otherwise contrary to, the statements in the Public Statement
or (ii) make any public statement (including any statement in any filing with the SEC or any other governmental agency) that is
critical of or disparages this Agreement, any of the parties hereto, or any actions taken prior to the date hereof by any of the
parties hereto in connection with the Annual Meeting; provided, however, that the parties hereto may make such statements
either required by applicable law, rule or regulation (including any statement required by any filing with the SEC or any other
governmental agency) or required in order to comply with the party’s fiduciary duties to the Company or its stockholders,
or the party’s investors or clients (as applicable), in each case as reasonably determined by the party seeking to make the
statement at issue, based on the advice of counsel and upon reasonable prior written notice to the other parties hereto of the
nature of the statement and the reasons it is required to be made, to the extent practicable under the circumstances.

 

    	-7-

    	 

    

 

5.2                Additional
Shares. The Stockholder shall promptly notify the Company of the number of shares of Common Stock, if any, as to which the
Stockholder acquires record or beneficial ownership after the date hereof until the conclusion of the Annual Meeting; provided
that in no event will the Stockholder have an obligation to provide notice to the Company under this Section 5.2 after the End
Date. Any shares of Common Stock as to which the Stockholder acquires record or beneficial ownership after the date hereof shall
be Owned Shares for purposes of this Agreement. Without limiting the foregoing, in the event of any stock split, stock dividend
or other change in the capital structure of the Company affecting the Common Stock, the number of shares of Common Stock constituting
Owned Shares shall be adjusted appropriately and this Agreement and the obligations hereunder shall attach to any additional shares
of Common Stock or other voting securities of the Company issued to the Stockholder in connection therewith.

 

5.3                Definition
of “Beneficial Ownership.” For purposes of this Agreement, “beneficial ownership” with respect to (or
to “beneficially own”) any securities shall mean having “beneficial ownership” of such securities as determined
pursuant to Rule 13d-3 under the Exchange Act, including pursuant to any agreement, arrangement or understanding, whether or not
in writing.

 

5.4                Expenses.
All costs and expenses incurred in connection with this Agreement and the obligations of the parties hereunder shall be paid by
the party incurring such costs and expenses.

 

5.5                Specific
Performance. The Stockholder, on the one hand, and the Company, on the other hand, acknowledge and agree that irreparable injury
to the other party hereto would occur in the event any of the provisions of this Agreement were not performed in accordance with
their specific terms or were otherwise breached and that such injury would not be adequately compensable in damages. It is accordingly
agreed that the Stockholder, on the one hand, and the Company, on the other hand (the “Moving Party”), shall each be
entitled to specific enforcement of, and injunctive relief to prevent any violation of, the terms hereof and the other party hereto
will not take action, directly or indirectly, in opposition to the Moving Party seeking such relief on the grounds that any other
remedy or relief is available at law or in equity, nor shall such other party seek the posting of a bond as a condition for obtaining
any such relief. An application for specific performance pursuant to this Section 5.5 shall not preclude the Moving Party from
seeking other relief available at law or in equity.

 

5.6                No
Waiver. Any waiver by either the Stockholder or the Company of a breach of any provision of this Agreement shall not operate
as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Agreement.
The failure of either party to insist upon strict adherence to any term of this Agreement on one or more occasions shall not be
considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term
of this Agreement. Any waiver of any provision of this Agreement must be signed by the party against whom enforcement of such waiver
is sought.

 

    	-8-

    	 

    

 

5.7                Successors
and Assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the
parties hereto (whether by operation of law or otherwise) without the prior written consent of the other parties. Subject to the
preceding sentence, this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective
successors and permitted assigns. Any purported assignment not permitted under this Section 5.7 shall be null and void.

 

5.8                Survival
of Representations. All representations and warranties made by the parties in this Agreement or pursuant hereto shall survive
the execution of this Agreement.

 

5.9                Entire
Agreement; Amendments. This Agreement, including the exhibits hereto, contains the entire understanding of the parties hereto
with respect to its subject matter. There are no restrictions, agreements, promises, representations, warranties, covenants or
undertakings other than those expressly set forth herein. This Agreement may not be modified, amended, altered or supplemented
except upon the execution and delivery of a written agreement executed by all of the parties hereto.

 

5.10                Severability.
The invalidity or unenforceability of any provision hereof in any jurisdiction will not affect the validity or enforceability of
the remainder hereof in that jurisdiction or the validity or enforceability of this Agreement, including that provision, in any
other jurisdiction. To the extent permitted by applicable law, each party waives any provision of applicable law that renders any
provision hereof prohibited or unenforceable in any respect. If any provision of this Agreement is held to be unenforceable for
any reason, it will be adjusted rather than voided, if possible, in order to achieve the intent of the parties to the extent possible.

 

5.11                Notices.
Any notice or other communication required or permitted to be given under this Agreement will be sufficient if it is in writing,
sent to the applicable address set forth below (or as otherwise specified by a party by notice to the other parties in accordance
with this Section 5.11) and delivered personally or sent by recognized overnight courier, postage prepaid, and will be deemed given
(a) when so delivered personally, (b) if sent by recognized overnight courier, one day after the date of sending, or
(c) if delivered by electronic mail transmission.

 

	 	If to the Company:
	 	 
	 	 	GlobalOptions Group, Inc.
	 	 	415 Madison Avenue
	 	 	New York, NY 10019
	 	 	Attn: Chief Executive Officer
	 	 	Email: hschiller@globaloptionsgroup.com
	 	 	 
	 	 	With a copy to:
	 	 	 
	 	 	Olshan Grundman Frome Rosenzweig & Wolosky LLP
	 	 	Park Avenue Tower
	 	 	65 East 55th Street
	 	 	New York, NY 10022
	 	 	Attn: Robert H. Friedman, Esq.
	 	 	Email: rfriedman@olshanlaw.com

 

    	-9-

    	 

    
 

	 	If to the Stockholder:
	 	 	 
	 	 	Genesis Capital Advisors LLC
	 	 	1212 Avenue of the Americas, 19th floor
	 	 	New York, New York 10036
	 	 	Attn: Ethan Benovitz
	 	 	 	   Daniel Saks
	 	 	Email: ebenovitz@genesiscm.com
	 	 	 	     dsaks@ genesiscm.com
	 	 	 
	 	 	With a copy to:
	 	 	 
	 	 	Haynes and Boone, LLP
	 	 	30 Rockefeller Plaza, 26th Floor
	 	 	New York, New York 10112
	 	 	Attn: Rick A. Werner, Esq.
	 	 	Email: rick.werner@haynesboone.com
	 	 	 	 	 

or to such other address as the person
to whom notice is given may have previously furnished to the others in writing in the manner set forth above.

 

5.12                Governing
Law; Jurisdiction. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State
of New York without reference to the conflict of laws principles thereof. The parties hereto agree to submit to the non-exclusive
jurisdiction of any court of competent jurisdiction located in the State of New York to resolve any dispute relating to this Agreement
and waive any right to move to dismiss or transfer any such action brought in any such court on the basis of any objection to personal
jurisdiction or venue.

 

5.13                Headings.
The section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning
or interpretation of this Agreement.

 

5.14                Counterparts.
This Agreement may be executed in counterparts, each of which shall be an original, but all of which together shall constitute
one and the same Agreement.

 

5.15                No
Admission. Nothing contained herein shall constitute an admission by any party hereto of liability or wrongdoing.

 

5.16                Further
Action. Each party agrees to, without further consideration, execute and deliver such additional documents, and take all such
further action as may be reasonably required to effectuate or further evidence the terms and provisions of this Agreement.

 

[Signature Page to Follow]

 

    	-10-

    	 

    

 

[Signature Page to Support Agreement]

 

IN WITNESS WHEREOF,
the parties hereto have duly executed this Agreement or caused this Agreement to be duly executed by their authorized representative,
as of the day and year first above written.

 

	 	GLOBALOPTIONS GROUP, INC.
	 	 	 
	 	By:	/s/ Jeffrey O. Nyweide
	 	Name:	Jeffrey O. Nyweide
	 	Title:	Chief Financial Officer and Executive Vice President
	 	 
	 	STOCKHOLDER:
	 	 	 
	 	GENESIS CAPITAL ADVISORS LLC
	 	 	 
	 	By:	/s/ Ethan Benovitz
	 	Name:	Ethan Benovitz
	 	Title:	Managing Member
	 	 	 
	 	GENESIS OPPORTUNITY FUND, L.P.
	 	 	 
	 	By:	/s/ Ethan Benovitz
	 	Name:	Ethan Benovitz
	 	Title:	Managing Member of G.P.
	 	 	 	 

	 	GENESIS ASSET OPPORTUNITY FUND, L.P.
	 	 	 
	 	By:	/s/ Ethan Benovitz
	 	Name:	Ethan Benovitz
	 	Title:	Managing Member of G.P.
	 	 	 	 

    	 

    	 

    

 

EXHIBIT A

 

OWNERSHIP OF COMMON STOCK

 

Common Stock Beneficially Owned as of the date hereof

 

	
        Beneficial
        Owner
	 	
        Shares
	 	
        Broker
	 
	Genesis Opportunity Fund, L.P.	 	1,535,529	 	 	 
	 	 	 	 	 	 
	Genesis Asset Opportunity Fund, L.P.	 	173,300	 	 	 

 

EXHIBIT B

 

FORM OF BOARD RESOLUTIONS

 

        RESOLVED,
that the Board of Directors hereby determines that each of Genesis Capital Advisors LLC, a Delaware limited liability company,
Genesis Opportunity Fund, L.P., a Delaware limited partnership, Genesis Asset Opportunity Fund, L.P., a Delaware limited partnership
and each of their respective Affiliates (as defined under the Rights Agreement) (collectively, the “Stockholder”) shall
not be deemed to be an “Acquiring Person” for the purposes of that certain Rights Agreement, dated as of September
7, 2010, by and between the Company and Continental Stock Transfer & Trust Company (the “Rights Agreement”) unless
and until the Stockholder becomes the “Beneficial Owner” (as defined under the Rights Agreement) of in excess of 35%
of the Common Shares (as defined under the Rights Agreement) then outstanding and provided that if at any time the Stockholder
is the Beneficial Owner (as defined under the Rights Agreement) of less than 25% of the Common Shares (as defined under the Rights
Agreement) then the Stockholder shall not be deemed to be an “Acquiring Person” for the purposes of the Rights Agreement,
unless and until the Stockholder becomes the “Beneficial Owner” (as defined under the Rights Agreement) of in excess
of 25% of the Common Shares (as defined under the Rights Agreement) then outstanding and provided further however, that if at any
time the Stockholder is the Beneficial Owner (as defined under the Rights Agreement) of less than 10% of the Common Shares (as
defined under the Rights Agreement) then the Stockholder shall not be deemed to be an “Acquiring Person” for the purposes
of the Rights Agreement, unless and until the Stockholder becomes the “Beneficial Owner” (as defined under the Rights
Agreement) of in excess of 10% of the Common Shares (as defined under the Rights Agreement) then outstanding; and be it further

 

        RESOLVED,
that the Board of Directors hereby acknowledges that the approval of the right to acquire up to 35% of the Company’s common
stock by the Stockholder thereby renders inapplicable such acquisitions of up to 35% of the Company’s Common Stock, the restrictions
on the Company from engaging in any business combination as set forth in Section 203 of the General Corporation Law of the State
of Delaware.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]